Multiple Sclerosis (MS) and Neuroimmunology
The Multiple Sclerosis and Neuroimmunology Center at Cedars-Sinai unites physician expertise with world-class research to help patients manage their symptoms and keep participating in activities they enjoy. The center features a team of specialists—including neurologists, ophthalmologists, rheumatologists and physical therapists. We have extensive experience in evaluation, diagnosis and treatment of patients with multiple sclerosis (MS) and related disorders.
Cedars-Sinai has been designated as a Partner in MS Care – Center for Comprehensive Care by the National Multiple Sclerosis Society. Our nationally recognized program delivers the best available treatments, along with the personalized attention you deserve.
Conditions We Treat
We have expertise in all forms of multiple sclerosis (MS) and neuroimmunological diseases, including rare conditions. We maintain a close relationship with you, allowing us to detect subtle signs that your diagnosis is changing.
A Patient’s Guide to MS and Neuroimmunological Diseases
We accurately confirm or rule out MS so you can get the care you need. You receive a thorough evaluation, including imaging tests that our MS experts analyze.
We deliver exceptional care that may reduce the frequency and severity of symptom flare-ups. You have access to the full range of MS medications.
If you're living with MS or a neuroimmunological disorder, you may have questions about testing and treatments. We provide helpful information to frequently asked questions.
Clinical Trials & Research
Our doctors are discovering new ways to diagnose and treat MS and other neurological conditions. Learn more about our clinical trials and research.
Medical Professionals & Postgraduates
The Neurology and Neurosurgery departments offer several programs for graduate studies, continuing medical education and other professional opportunities.
Second Opinion Identifies Rare Immune Disorder
In 2018 Sarah Bowe woke up with a tingling sensation throughout her lower body. What happened next resulted in a misdiagnosis of MS resulting instead in a rare and only recently identified neuroimmune disorder called MOG antibody-associated disease.